Renalytix PLC (RNLX)
0.5157
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
0.5069
-0.01
(-1.71%)
After-Hours: 06:20
Renalytix Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 28, 2024 | 19.33 |
March 27, 2024 | 20.46 |
March 26, 2024 | 19.86 |
March 25, 2024 | 20.38 |
March 22, 2024 | 22.18 |
March 21, 2024 | 20.70 |
March 20, 2024 | 20.46 |
March 19, 2024 | 22.48 |
March 18, 2024 | 23.38 |
March 15, 2024 | 19.33 |
March 14, 2024 | 19.76 |
March 13, 2024 | 15.08 |
March 12, 2024 | 17.03 |
March 11, 2024 | 21.36 |
March 08, 2024 | 20.42 |
March 07, 2024 | 21.92 |
March 06, 2024 | 22.29 |
March 05, 2024 | 24.54 |
March 04, 2024 | 27.54 |
March 01, 2024 | 19.48 |
February 29, 2024 | 21.92 |
February 28, 2024 | 15.55 |
February 27, 2024 | 15.46 |
February 26, 2024 | 13.90 |
February 23, 2024 | 12.59 |
Date | Value |
---|---|
February 22, 2024 | 13.91 |
February 21, 2024 | 12.66 |
February 20, 2024 | 14.05 |
February 16, 2024 | 15.91 |
February 15, 2024 | 14.71 |
February 14, 2024 | 22.67 |
February 13, 2024 | 26.42 |
February 12, 2024 | 23.42 |
February 09, 2024 | 7.140 |
February 08, 2024 | 10.14 |
February 07, 2024 | 5.152 |
February 06, 2024 | 4.903 |
February 05, 2024 | 5.322 |
February 02, 2024 | 5.853 |
February 01, 2024 | 5.618 |
January 31, 2024 | 5.935 |
January 30, 2024 | 5.995 |
January 29, 2024 | 5.993 |
January 26, 2024 | 5.993 |
January 25, 2024 | 5.826 |
January 24, 2024 | 5.993 |
January 23, 2024 | 5.433 |
January 22, 2024 | 5.620 |
January 19, 2024 | 4.864 |
January 18, 2024 | 4.890 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.566
Minimum
Sep 27 2022
27.54
Maximum
Mar 04 2024
9.700
Average
9.586
Median
Price to Book Value Benchmarks
TC BioPharm (Holdings) PLC | 3.988 |
Ainos Inc | 0.2771 |
Aptorum Group Ltd | 1.064 |
Adaptimmune Therapeutics PLC | 11.53 |
Biodexa Pharmaceuticals Plc | 0.9345 |
Price to Book Value Related Metrics
PS Ratio | 11.15 |
Price | 0.5157 |
Earnings Yield | -151.3% |
Market Cap | 38.04M |